These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34182241)

  • 1. Conformation-specific monoclonal antibodies recognizing the native structure of G protein-coupled receptor (GPCR).
    Isozaki Y; Tsumoto K; Tomita M
    Int Immunopharmacol; 2021 Sep; 98():107872. PubMed ID: 34182241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of stereospecific targeting technique for selective production of monoclonal antibodies against native ephrin type-A receptor 2.
    Yamasaki Y; Miyamae C; Isozaki Y; Ichikawa K; Kaneko Y; Oda Y; Murayama T; Sakurai T; Tamai K; Tsumoto K; Tomita M
    J Immunol Methods; 2020; 484-485():112813. PubMed ID: 32592774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
    Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
    MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of monoclonal antibodies against the free alpha-subunit of human chorionic gonadotrophin.
    Novo C; Domingos A; Karmali A
    Mol Biotechnol; 2001 Feb; 17(2):119-28. PubMed ID: 11395860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced hybridoma technology for selective production of high-affinity monoclonal antibodies through B-cell receptors.
    Sakashita K; Tsumoto K; Tomita M
    J Immunol Methods; 2022 Dec; 511():113384. PubMed ID: 36372268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of high-affinity monoclonal antibody using CD44 overexpressed cells as a candidate for targeted immunotherapy and diagnosis of acute myeloid leukemia.
    Amanzadeh A; Heidarnejad F; Abdollahpour-Alitappeh M; Molla-Kazemiha V; Yari S; Hadizadeh-Tasbiti A; Habibi-Anbouhi M; Abolhassani M; Shokrgozar MA
    Hum Antibodies; 2017; 26(1):7-15. PubMed ID: 28269763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodies.
    Scott MJ; Jowett A; Orecchia M; Ertl P; Ouro-Gnao L; Ticehurst J; Gower D; Yates J; Poulton K; Harris C; Mullin MJ; Smith KJ; Lewis AP; Barton N; Washburn ML; de Wildt R
    MAbs; 2020; 12(1):1755069. PubMed ID: 32343620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1.
    Douthwaite JA; Sridharan S; Huntington C; Hammersley J; Marwood R; Hakulinen JK; Ek M; Sjögren T; Rider D; Privezentzev C; Seaman JC; Cariuk P; Knights V; Young J; Wilkinson T; Sleeman M; Finch DK; Lowe DC; Vaughan TJ
    MAbs; 2015; 7(1):152-66. PubMed ID: 25484051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and characterization of monoclonal antibodies against recombinant extracellular domain of CD99.
    Thangaretnam KP; Paramasivam OR; Ramanathan P; Gopisetty G; Rajkumar T
    Hum Antibodies; 2019; 27(1):69-83. PubMed ID: 30282350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of a panel of monoclonal antibodies specific for human fibroblast growth factor receptor 4 (FGFR4).
    Chen C; Patel S; Corisdeo S; Liu X; Micolochick H; Xue J; Yang Q; Lei Y; Wang B; Soltis D
    Hybridoma (Larchmt); 2005 Jun; 24(3):152-9. PubMed ID: 15943563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and Characterization of Siglec-F-Specific Monoclonal Antibodies.
    Shahmohammadi-Farid S; Ghods R; Jeddi-Tehrani M; Bayat AA; Mojtabavi N; Razavi A; Zarnani AH
    Iran J Allergy Asthma Immunol; 2017 Dec; 16(6):460-470. PubMed ID: 29338152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparation and identification of monoclonal antibody against human thrombomodulin.].
    Guo ZF; He SY; Zhu BY; Yan PK; Li BY; Liao DF
    Sheng Li Xue Bao; 2006 Aug; 58(4):391-6. PubMed ID: 16906342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of novel monoclonal antibodies against tartrate-resistant acid phosphatase 5.
    Ohashi T; Miura T; Igarashi Y; Kiyokawa I; Sato Y; Sasagawa K; Katagiri K; Mochizuki Y; Tomonaga T; Nomura F; Kojima R; Katayama K
    Hybridoma (Larchmt); 2006 Dec; 25(6):358-66. PubMed ID: 17203998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of monoclonal antibodies against human CD20 in Balb/c mice.
    Sepehr KS; Baradaran B; Majidi J; Abdolalizadeh J; Aghebati L; Shahneh FZ
    Hum Antibodies; 2012; 21(3-4):57-64. PubMed ID: 23549022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors.
    Bruckheimer EM; Fazenbaker CA; Gallagher S; Mulgrew K; Fuhrmann S; Coffman KT; Walsh W; Ready S; Cook K; Damschroder M; Kinch M; Kiener PA; Woods R; Gao C; Dall'Acqua W; Wu H; Coats S
    Neoplasia; 2009 Jun; 11(6):509-17, 2 p following 517. PubMed ID: 19484140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human IgG antibodies recognizing distinct extracellular domains of EGF receptor exhibit different degrees of growth inhibitory effects on human A431 cancer cells.
    Chang C; Takayanagi A; Yoshida T; Shimizu N
    Exp Cell Res; 2013 May; 319(8):1146-55. PubMed ID: 23499740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to human estrogen receptor.
    Greene GL; Nolan C; Engler JP; Jensen EV
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5115-9. PubMed ID: 7001472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of specific monoclonal antibodies against the extracellular loops of human claudin-3 by immunizing mice with target-expressing cells.
    Ando H; Suzuki M; Kato-Nakano M; Kawamoto S; Misaka H; Kimoto N; Furuya A; Nakamura K
    Biosci Biotechnol Biochem; 2015; 79(8):1272-9. PubMed ID: 25744656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid screening and production method using a novel mammalian cell display to isolate human monoclonal antibodies.
    Tomimatsu K; Matsumoto SE; Tanaka H; Yamashita M; Nakanishi H; Teruya K; Kazuno S; Kinjo T; Hamasaki T; Kusumoto K; Kabayama S; Katakura Y; Shirahata S
    Biochem Biophys Res Commun; 2013 Nov; 441(1):59-64. PubMed ID: 24140057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and characterization of monoclonal antibodies to pituitary adenylate cyclase activating polypeptide type I receptor.
    Zvirblienë A; Zvirblis G; Cao YJ; Fahrenholz F
    Hybridoma; 1999 Aug; 18(4):335-42. PubMed ID: 10571263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.